News | December 19, 2022
Stake sale in GMM Pfaudler by Pfaudler
Post the sale, Patel family has become the single largest promoter shareholder in the company
Post the sale, Patel family has become the single largest promoter shareholder in the company
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
The proceeds of the issue has been/will be reinvested in the company and to meet its own business requirements.
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
TTK Healthcare Limited received from BSV Pharma Pvt. Ltd. a sum of Rs. 593.11 crore on 9th May, 2022
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
This will enable the company to consume 100% of the solar energy to be supplied by Ethan Energy India Private Limited from their 10 MW Solar Energy plant
Acquisition expands Merck’s growing hematology portfolio
Subscribe To Our Newsletter & Stay Updated
